Zheng Li usually goes around the public experimental area in the morning, listens to everyone's questions, and casually gives some ideas.
Then he returned to the 17th floor where he was the only one. Apart from him, there were only different kinds of experimental animals on the 17th floor.
The mainstream biological experimental animals used are generally mice, and then there are also some more common animals, such as macaques, orangutans, dogs, rabbits, etc.
Cows and sheep used in experiments are relatively rare, but sheep are the most famous. The first cloned animal was Dolly the sheep.
The largest population in Zheng Li's laboratory is white mice, and the largest area is macaques.
With the rapid growth of domestic biopharmaceutical research and development and the continuous improvement of domestic new drug safety evaluation requirements, the amount of monkeys required for preclinical research is increasing year by year.
In addition, experimental monkeys are highly susceptible to epidemics due to their high genetic homology with humans, making them the most effective experimental animal subjects after the outbreak.
The price of experimental monkeys has been soaring. The domestic price has climbed from 60,000 per monkey at the beginning of the year to nearly 100,000 per monkey now.
The Lion City is more expensive, with experimental monkeys generally costing 120,000.
In the previous verification stage, mice were used to implant the most basic magic brain into the mice. This most basic magic brain can only allow creatures to have the ability to influence reality through instinct, and cannot accurately achieve what you want. become reality.
Just like you can't achieve level 0 magic hands in the DND system through the most basic magic brain.
The Master has always believed in the existence of human souls since his birth, and later developed into believing that all intelligent beings have souls.
But for a long time, mages were unable to verify this view, just like humans believed in the existence of gods in the past, but could not verify it.
With the development of the times, mages have directly observed the existence of souls through research.
Later, mages discovered that memory, soul and body are the components of intelligent life.
To describe it using the computer system that Blue Star is familiar with, the body is the hardware, the soul is the middleware, and the memory is the system and software.
This breakthrough discovery came after the mages developed space teleportation. They found that it was possible to teleport items, but if the teleporter was an intelligent creature, he could only act instinctively after teleportation.
So the mage seriously suspected that teleportation caused intelligent creatures to lose their souls, and later successfully proved this.
Until the time when Zheng Li came to Blue Star, the mage still had not developed a way to transmit soul, body and memory together.
The soul, memory, and body are like an impossible triangle. When a space jump occurs, only two of the three can exist.
In other words, in Blue Star’s time-travel novel, soul travel is possible, but body travel is impossible.
In addition, the matching degree between the soul and the magic brain is directly related to the ability to cast spells. In the Mage Alliance, standard magic brains will be given, but some people will choose to go to specialized institutions to customize the magic brain.
The reason why Zheng Li needs experimental monkeys is because monkeys are also considered intelligent creatures and they also have souls.
How to match the artificial demon brain with the soul, he needs to test it on experimental monkeys.
The research and development work of artificial magic brain is lengthy and easily tiring. Fortunately, there are accurate goals and complete theoretical support, so that people will not lose confidence and fighting spirit.
(The specific experimental steps are a bit disgusting, so I won’t write them down. I originally wrote 500 words and I was disgusted, so I forgot about it.)
To put it simply, the embryonic magic brain is implanted into the embryo in the female monkey, and the embryo that is not yet fully formed but has a soul is taken out, and then the matching degree is observed through a specific device.
Finally, the embryos are processed.
...
At the beginning of 2021, one year has passed since the epidemic was discovered, and the epidemic has not improved at all. To be precise, it has not improved worldwide, but has intensified.
The global demand for endorphins continues to grow. Previously, Kechuang Biotech’s external technology licensing period was five years. Even when it was licensed to other companies, endorphins were still in short supply.
Because alpha-endorphin reduces the addictive effects of opioids, the number of people purchasing endorphins has increased significantly. Canada has taken the lead in announcing that it will provide endorphins to "addicts" for free within the month in order to reduce their addiction to drugs. Addictive.
Some countries in Europe and Australia have followed suit, leading to further growth in demand for endorphins.
Since endorphins need to work together with lipotropic tryptic peptides to exert their addictive-reducing effects, the demand for lipotropic tryptic peptides has also been growing.
The management of Kechuang Biotech does not want to see the market occupied by other authorized pharmaceutical companies, so they also want to expand the production of endorphins.
The current annual output of endorphins at the production base in Suzhou is about 16,000L, which has doubled from the middle of the year.
After the opening of the Lion City R&D Center, the money on Kechuang Biotech's books was spent like water.
The small shareholders of Kechuang Biotech all hope that Kechuang Biotech will start the next round of venture capital investment, while the management of Kechuang Biotech hopes to go public directly.
Because Kechuang Bio is listed on the market, they can get options and achieve financial freedom. If Ke Chuang Bio’s C round of venture capital investment, there is a high probability that there will not be a dedicated option pool for the management.
Zheng Li does not want to further dilute his shares in Kechuang Biotechnology. If he conducts the next round of venture capital, his equity will most likely drop to less than 50% when the company goes public.
Dropping below 50% means that Science and Technology Creation is no longer his main concern. If the Demonic Brain does not make progress, his life may not be as easy as it is now.
"If we want to go public, it is best to list on the A-share market. Listing on the US stock market in the current form may not be a good thing." Li Miaomiao said.
Zheng Li nodded: "You discuss these matters first, come up with a plan and then report to me."
After Kechuang Biotech released rumors that it was going to be listed, major securities firms broke through the door of Kechuang Biotech.
Let’s put it this way: a total of 145 companies were listed on the Science and Technology Innovation Board in 2020, and these companies raised a total of 222.622 billion yuan in funds.
The valuation of Kechuang Biotechnology is about 120 billion yuan, and the funds raised are at least 72 billion yuan.
This is because the Science and Technology Innovation Board must issue at least 10% of the shares.
After Endorphin was launched in China, Kechuang Biotechnology has been hailed as the largest unicorn company in China. The purpose of this listing is to expand the production scale of Endorphin.
For securities companies, this is a sure-profit business, and for the investment banking department of securities companies, the investment in Kechuang Biotech can satisfy the full-year performance.
What's more satisfying than completing the entire year's marketing at the beginning of the year?
In addition to the two brothers CITIC and CITIC Construction Investment, Soochow Securities, a local company in Suzhou, is the most active.
For an IPO of this scale, small securities firms generally have no chance. Soochow Securities relies on its headquarters in Suzhou to try to win the deal.
